Contribution of follicular dendritic cells to persistent HIV viremia
- PMID: 23658450
- PMCID: PMC3700220
- DOI: 10.1128/JVI.00556-13
Contribution of follicular dendritic cells to persistent HIV viremia
Erratum in
- J Virol. Jul;87(14):7893
Abstract
HIV-1 infections cannot be completely eradicated by drug therapy, as the virus persists in reservoirs. Low-level plasma viremia has been detected in patients treated for over 7 years, but the cellular compartments that support this low-level viremia have not been identified. The decay of HIV-1 during treatment appears to occur in four phases, with the 3rd and 4th phases occurring when the virus is below the limit of detection of conventional assays. Here, we focus on the 3rd phase of decay, which has been estimated to have a half-life of 39 months. We show that follicular dendritic cells (FDC), which have been identified as an HIV reservoir, can be the main source of the low-level viremia detected during the 3rd phase of decay and contribute to viremia at even longer times. Our calculations show that the kinetics of leakage of virus from FDC is consistent with three types of available clinical data.
Figures









Similar articles
-
Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node.Front Immunol. 2018 Apr 19;9:805. doi: 10.3389/fimmu.2018.00805. eCollection 2018. Front Immunol. 2018. PMID: 29725333 Free PMC article. Review.
-
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.J Infect Dis. 2004 Jan 1;189(1):51-60. doi: 10.1086/380509. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702153 Clinical Trial.
-
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV].Transfus Clin Biol. 2003 Apr;10(2):72-3. doi: 10.1016/s1246-7820(03)00025-9. Transfus Clin Biol. 2003. PMID: 12763147 French. No abstract available.
-
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84. doi: 10.1073/pnas.0800050105. Epub 2008 Mar 10. Proc Natl Acad Sci U S A. 2008. PMID: 18332425 Free PMC article.
-
Time to HIV-1 RNA suppression below 5 copies/ml during first-line protease inhibitor-based antiretroviral treatment - any impact of residual viremia on treatment success?AIDS Rev. 2013 Oct-Dec;15(4):230-6. AIDS Rev. 2013. PMID: 24322383 Review.
Cited by
-
HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.Cells. 2022 Sep 23;11(19):2968. doi: 10.3390/cells11192968. Cells. 2022. PMID: 36230931 Free PMC article.
-
Epigenetic Mechanisms of HIV-1 Persistence.Vaccines (Basel). 2021 May 17;9(5):514. doi: 10.3390/vaccines9050514. Vaccines (Basel). 2021. PMID: 34067608 Free PMC article. Review.
-
Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node.Front Immunol. 2018 Apr 19;9:805. doi: 10.3389/fimmu.2018.00805. eCollection 2018. Front Immunol. 2018. PMID: 29725333 Free PMC article. Review.
-
Are T cells the only HIV-1 reservoir?Retrovirology. 2016 Dec 20;13(1):86. doi: 10.1186/s12977-016-0323-4. Retrovirology. 2016. PMID: 27998285 Free PMC article. Review.
-
Insight into treatment of HIV infection from viral dynamics models.Immunol Rev. 2018 Sep;285(1):9-25. doi: 10.1111/imr.12698. Immunol Rev. 2018. PMID: 30129208 Free PMC article. Review.
References
-
- Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126 - PubMed
-
- Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582–1586 - PubMed
-
- Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188–191 - PubMed
-
- Finzi D, Siliciano RF. 1998. Viral dynamics in HIV-1 infection. Cell 93:665–671 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical